{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Ta de Clinicagem","title":"TdC 160: 7 armadilhas de DOACs","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/119e2686\"></iframe>","width":"100%","height":180,"duration":2481,"description":"🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨\r\n🔴 Junte-se aos mais de 1.500 assinantes. Assine o Guia, ganhe tempo e atualize-se sem esforço.\r\n🟠 Um serviço de revisão e atualização continuados em clínica médica. A informação que você precisa, do jeito que você prefere.\r\n📚 Confira agora mesmo a edição aberta do Guia TdC sobre a nova diretriz de Insuficiência Cardíaca (IC) da American Heart Association (AHA): https://www.tadeclinicagem.com.br/guia/2/diretriz-de-insuficiencia-cardiaca-aha-2022/.\r\n\r\nIago, Gui e Ingrid discutem 7 armadilhas do uso de DOACs!\r\n\r\nReferências:\r\n1) Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013 Feb 21;368:699-708.\r\n2) Bikdeli B, Tajrishi FZ, Sadeghipour P, Talasaz AH, Fanikos J, Lippi G, Siegal DM, Eikelboom JW, Monreal M, Jimenez D, Connors JM. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA cardiology.\r\n3) Weitz JI, Lensing AW, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MC. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. New England Journal of Medicine. 2017 Mar 30;376(13):1211-22.\r\n4) Eikelboom JW, Bhatt DL, Fox KA, Bosch J, Connolly SJ, Anand SS, Avezum A, Berkowitz SD, Branch KR, Dagenais GR, Félix C. Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease. Journal of the American College of Cardiology. 2021 Jul 6;78(1):14-23.\r\n5) Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P. Rivaroxaban with or without aspirin in stable cardiovascular disease. New England Journal of Medicine. 2017 Oct 5;377(14):1319-30.\r\n6) Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM, Wirth D, Kaatz S. Reversal of direct oral...","thumbnail_url":"https://img.transistorcdn.com/lqcQlEC1m6aWV5CJqKTqNKKWbLXziZKK97FisF4ZuuE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lODM1/ZmI0ODIxZjAxM2U1/ZGUwMjhkYTYwNzZi/MGNmNi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}